Title : The influences of CYP2C9*1/*3 genotype on the pharmacokinetics of zolpidem.

Pub. Date : 2018 Sep

PMID : 30178440






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The influences of CYP2C9*1/*3 genotype on the pharmacokinetics of zolpidem. Zolpidem cytochrome P450 family 2 subfamily C member 9 Homo sapiens
2 Zolpidem is predominantly metabolized by CYP3A4, and to a lesser extent by CYP2C9, CYP1A2, CYP2D6 and CYP2C19. Zolpidem cytochrome P450 family 2 subfamily C member 9 Homo sapiens
3 The aim of this study was to identify the effects of CYP2C9*3 allele on the pharmacokinetics of zolpidem. Zolpidem cytochrome P450 family 2 subfamily C member 9 Homo sapiens
4 In addition, since zolpidem is metabolized at a high rate by CYP3A4, the effect of CYP2C9*3 allele on the pharmacokinetics of zolpidem was also observed in the condition where CYP3A4 was sufficiently inhibited by the steady-state concentration of clarithromycin, a potent CYP3A4 inhibitor. Zolpidem cytochrome P450 family 2 subfamily C member 9 Homo sapiens
5 In addition, since zolpidem is metabolized at a high rate by CYP3A4, the effect of CYP2C9*3 allele on the pharmacokinetics of zolpidem was also observed in the condition where CYP3A4 was sufficiently inhibited by the steady-state concentration of clarithromycin, a potent CYP3A4 inhibitor. Zolpidem cytochrome P450 family 2 subfamily C member 9 Homo sapiens